The proportion of women diagnosed with breast cancer at 40 years of age or younger who undergo BRCA1 and BRCA2 mutation testing is increasing, according to a new study. In fact, the proportion went from 77% in 2006 to 95% in 2013, Shoshana M. Rosenberg, ScD, MPH, from the Dana-Farber Cancer Institute in Boston, and colleagues report in their study, which was published online February 11 in JAMA Oncology. Read more…
